23.11.2016 • NewsElaine Burridgefeedstockfertilizer

OCP and Ethiopia in $3.7 Billion Fertilizer Project

Leading phosphate exporter Office Cherifien des Phosphates (OCP) has signed an agreement with the Ethiopian Ministry of Public Enterprise to build a $3.7 billion fertilizer plant in the east African country. OCP, which is 95% owned by the Moroccan government, said the "game-changing partnership" is based on a common vision between Morocco and Ethiopia for sustainable agricultural development across Africa and reinforces economic ties between the two countries.

The first phase of the project will see $2.4 billion invested in a plant in Dire Dawa, 250 kilometers east of the capital Addis Ababa, to produce 2.5 million t/y of fertilizer. Start-up is slated for mid-2022. Part of the investment will also be spent on developing infrastructure at Djibouti harbor to handle the phosphoric acid imported from OCP in Morocco. Potash and ammonia feedstocks will be sourced from Ethiopia.

OCP said 60% of the first-phase investment will come from debt financing with the rest in equal shares from the two partners. A second-phase investment of $1.3 billion will be made to raise capacity to 3.8 million t/y by 2025. The plant’s output is expected to more than meet all of Ethiopia's fertilizer demand with the excess being exported, aided by a new railway line that will connect the plant to neighboring countries.

Ethiopia's agricultural sector is said to account for 45% of the country's GDP and 90% of its exports. According to the World Bank, Ethiopia is the second most populous country in Sub-Saharan Africa with GDP growth of 9.6% in 2015. 

 

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.